Health and Fitness Health and Fitness
Mon, December 19, 2011
[ Mon, Dec 19th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Securities Laws Violations by Invacare Corporatio
[ Mon, Dec 19th 2011 ] - Market Wire
Positron Recieves Indiana Board of Pharmacy License
[ Mon, Dec 19th 2011 ] - Market Wire
Three Former Federal Law Enforcement Agents Want .. Marijuana Through Washington State Initiative 502
[ Mon, Dec 19th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation into Invacare Corporation
[ Mon, Dec 19th 2011 ] - Market Wire
Impax Pharmaceuticals Initiates Phase IIb Trial of IPX159 in Restless Legs Syndrome
[ Mon, Dec 19th 2011 ] - Market Wire
International Drug & Explosives Detection Company IDenta Corp. to Begin Reporting Financials
[ Mon, Dec 19th 2011 ] - Market Wire
Abbott and University of Illinois Establish Center for Nutrition, Learning and Memory
[ Mon, Dec 19th 2011 ] - Market Wire
Imaging Diagnostic Systems Assigns ID-Matrix Systems as Exclusive Distributor for China
[ Mon, Dec 19th 2011 ] - Market Wire
Southern California Investment Forum Hosts an Inv .. hering Today at the Pacific Club in Newport Beach
[ Mon, Dec 19th 2011 ] - Market Wire
Celsion Completes Consultative Review Process Wit .. EAT Study of ThermoDox(R) in Primary Liver Cancer
[ Mon, Dec 19th 2011 ] - Market Wire
Exactech Initiates Multi-Center Clinical Trial for New Cartilage Regeneration Technology
[ Mon, Dec 19th 2011 ] - Market Wire
Verisante Obtains Australian Approval
[ Mon, Dec 19th 2011 ] - Market Wire
Rosetta Genomics Sells Ownership in Rosetta Green
[ Mon, Dec 19th 2011 ] - Market Wire
BioElectronics Announces Chinese Patent
[ Mon, Dec 19th 2011 ] - Market Wire
Ohr Pharmaceutical Announces $1,100,000 Private Placement Led by Existing Investors
[ Mon, Dec 19th 2011 ] - Market Wire
ALS Therapy Development Institute Announces Resea .. c and UCB to Investigate the Role of CD40L in ALS
[ Mon, Dec 19th 2011 ] - Market Wire
Health Net to Hold Conference Call and Webcast to .. Fourth Quarter and Year-End 2011 Earnings Results
[ Mon, Dec 19th 2011 ] - Market Wire
Unigene's 2011 Year in Review - Key Elements in Place to Address Debt in 2012
[ Mon, Dec 19th 2011 ] - Market Wire
Medical Centers Worldwide Adopt Both Accuray's CyberKnife and TomoTherapy Systems
[ Mon, Dec 19th 2011 ] - Market Wire
Cynosure to Present at 14th Annual Needham Growth Conference
[ Mon, Dec 19th 2011 ] - Market Wire
Daxor Announces the Veterans Affairs New York Har .. HS) Acquires BVA-100 Blood Volume Analyzer &&#
[ Mon, Dec 19th 2011 ] - Market Wire
Delaware Chancery Court Denies SIGA Technologies' Motion for Reargument
[ Mon, Dec 19th 2011 ] - Market Wire
Zimmer Initiates Quarterly Dividend and Announces New Share Repurchase Program
[ Mon, Dec 19th 2011 ] - Market Wire
Kindred Healthcare Promotes Patricia M. Henry to President of RehabCare Division
[ Mon, Dec 19th 2011 ] - Market Wire
Equity Research on St. Jude Medical Inc. and Medt .. nt Cutbacks Affecting Medical Appliances &;
[ Mon, Dec 19th 2011 ] - Market Wire
Isis Initiates Phase 1 Clinical Study of ISIS-SMNRx in Patients With Spinal Muscular Atrophy
[ Mon, Dec 19th 2011 ] - Market Wire
Somaxon Pharmaceuticals Hires Financial Advisor to Assist in Seeking Strategic Alternatives
[ Mon, Dec 19th 2011 ] - Market Wire
Galectin Therapeutics Provides Corporate Update
[ Mon, Dec 19th 2011 ] - Market Wire
Ardea Biosciences Initiates Phase 3 Clinical Development Program for Lesinurad
[ Mon, Dec 19th 2011 ] - Market Wire
Valeant Pharmaceuticals Completes Acquisition of Dermik

Valeant Pharmaceuticals Completes Acquisition of Dermik


Published on 2011-12-19 05:07:49 - Market Wire
  Print publication without navigation


Valeant Pharmaceuticals Completes Acquisition of Dermik -- MISSISSAUGA, Ontario, Dec. 19, 2011 /PRNewswire/ --

Valeant Pharmaceuticals Completes Acquisition of Dermik

[ ]
[ ]

[ Download image ]

  

 

 

 

MISSISSAUGA, Ontario, Dec. 19, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: [ VRX ] and TSX: VRX) announced that effective December 16, 2011, the company completed its previously announced acquisition of Dermik, a dermatology unit of Sanofi (EURONEXT: SAN and NYSE: SNY).

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at [ www.valeant.com ].

Contact Information:
Laurie W. Little
949-461-6002
[ laurie.little@valeant.com ]

 

SOURCE Valeant Pharmaceuticals International, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.valeant.com ]

Contributing Sources